Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 11/2016

10.09.2016 | Assisted Reproduction Technologies

Building a model to increase live birth rate through patient-specific optimization of embryo transfer day

verfasst von: R. H. Goldman, D. J. Kaser, S. A. Missmer, S. S. Srouji, L. V. Farland, C. Racowsky

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Many practices are moving away from cleavage-stage transfer in favor of blastocyst transfer. The purpose of this study is to evaluate how the overall live birth rate for fresh IVF cycles may increase by optimizing the day of transfer for each patient.

Methods

This is a retrospective cohort study of 1225 first fresh autologous IVF cycles performed between May 2012 and November 2013. Stepwise logistic regression was used to determine characteristics associated with live birth following cleavage-stage versus blastocyst transfer. The optimal transfer day (i.e., the day that maximized the odds of live birth) was determined for each patient, and the actual live birth rate was compared with the projected rate had each patient undergone transfer on her optimal day.

Results

With transfer on the optimal day for each patient, the overall birth rate would have increased from its actual value of 34.8 % to a projected 43.0 %, a 24 % increase. The majority of this increase (21 %) was due to optimization of patients who underwent cleavage-stage transfer but had a higher projected birth rate from blastocyst transfer. These patients were older (37.8 versus 36.0 years, p < 0.01) and had more follicles ≥18 mm than patients who should have remained with a cleavage-stage transfer.

Conclusions

A model can be built enabling patient-specific identification of optimal transfer day; within this discovery cohort, such optimization was estimated to increase live birth following a fresh transfer by 24 %. This study suggests blastocyst transfer should be more widely offered; however, there remain patients for whom a cleavage-stage transfer may yield better outcomes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2012;7:CD002118. Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2012;7:CD002118.
2.
Zurück zum Zitat Marsh CA, Farr SL, Chang J, Kissin DM, Grainger DA, Posner SF, et al. Trends and factors associated with the day 5 embryo transfer, assisted reproductive technology surveillance, USA, 2001–2009. Hum Reprod. 2012;27:2325–31.CrossRefPubMed Marsh CA, Farr SL, Chang J, Kissin DM, Grainger DA, Posner SF, et al. Trends and factors associated with the day 5 embryo transfer, assisted reproductive technology surveillance, USA, 2001–2009. Hum Reprod. 2012;27:2325–31.CrossRefPubMed
3.
Zurück zum Zitat Jones GM, Trounson AO. Blastocyst stage transfer: pitfalls and benefits. The benefits of extended culture. Hum Reprod. 1999;14:1405–8.CrossRefPubMed Jones GM, Trounson AO. Blastocyst stage transfer: pitfalls and benefits. The benefits of extended culture. Hum Reprod. 1999;14:1405–8.CrossRefPubMed
4.
Zurück zum Zitat Thomas MR, Sparks AE, Ryan GL, Van Voorhis BJ. Clinical predictors of human blastocyst formation and pregnancy after extended embryo culture and transfer. Fertil Steril. 2010;94:543–8.CrossRefPubMed Thomas MR, Sparks AE, Ryan GL, Van Voorhis BJ. Clinical predictors of human blastocyst formation and pregnancy after extended embryo culture and transfer. Fertil Steril. 2010;94:543–8.CrossRefPubMed
5.
Zurück zum Zitat Gardner DK, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft WB. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril. 1998;69:84–8.CrossRefPubMed Gardner DK, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft WB. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril. 1998;69:84–8.CrossRefPubMed
6.
Zurück zum Zitat Mangalraj AM, Muthukumar K, Aleyamma T, Kamath MS, George K. Blastocyst stage transfer vs cleavage stage embryo transfer. J Hum Reprod Sci. 2009;2:23–6.CrossRefPubMedPubMedCentral Mangalraj AM, Muthukumar K, Aleyamma T, Kamath MS, George K. Blastocyst stage transfer vs cleavage stage embryo transfer. J Hum Reprod Sci. 2009;2:23–6.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B, et al. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod. 2008;23:91–9.CrossRefPubMed Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B, et al. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod. 2008;23:91–9.CrossRefPubMed
8.
Zurück zum Zitat Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med. 2006;354:1139–46.CrossRefPubMed Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med. 2006;354:1139–46.CrossRefPubMed
9.
Zurück zum Zitat Zech NH, Lejeune B, Puissant F, Vanderzwalmen S, Zech H, Vanderzwalmen P. Prospective evaluation of the optimal time for selecting a single embryo for transfer: day 3 versus day 5. Fertil Steril. 2007;88:244–6.CrossRefPubMed Zech NH, Lejeune B, Puissant F, Vanderzwalmen S, Zech H, Vanderzwalmen P. Prospective evaluation of the optimal time for selecting a single embryo for transfer: day 3 versus day 5. Fertil Steril. 2007;88:244–6.CrossRefPubMed
10.
Zurück zum Zitat Rienzi L, Ubaldi F, Iacobelli M, Ferrero S, Minasi MG, Martinez F, et al. Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Hum Reprod. 2002;17:1852–5.CrossRefPubMed Rienzi L, Ubaldi F, Iacobelli M, Ferrero S, Minasi MG, Martinez F, et al. Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Hum Reprod. 2002;17:1852–5.CrossRefPubMed
11.
Zurück zum Zitat Van der Auwera I, Debrock S, Spiessens C, Afschrift H, Bakelants E, Meuleman C, et al. A prospective randomized study: day 2 versus day 5 embryo transfer. Hum Reprod. 2002;17:1507–12.CrossRefPubMed Van der Auwera I, Debrock S, Spiessens C, Afschrift H, Bakelants E, Meuleman C, et al. A prospective randomized study: day 2 versus day 5 embryo transfer. Hum Reprod. 2002;17:1507–12.CrossRefPubMed
12.
Zurück zum Zitat Frattarelli JL, Leondires MP, McKeeby JL, Miller BT, Segars JH. Blastocyst transfer decreases multiple pregnancy rates in in vitro fertilization cycles: a randomized controlled trial. Fertil Steril. 2003;79:228–30.CrossRefPubMed Frattarelli JL, Leondires MP, McKeeby JL, Miller BT, Segars JH. Blastocyst transfer decreases multiple pregnancy rates in in vitro fertilization cycles: a randomized controlled trial. Fertil Steril. 2003;79:228–30.CrossRefPubMed
13.
Zurück zum Zitat Maheshwari A, Kalampokas T, Davidson J, Bhattacharya S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of blastocyst-stage versus cleavage-stage embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril. 2013;100:1615–21.e1–10.CrossRefPubMed Maheshwari A, Kalampokas T, Davidson J, Bhattacharya S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of blastocyst-stage versus cleavage-stage embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril. 2013;100:1615–21.e1–10.CrossRefPubMed
14.
Zurück zum Zitat Dar S, Lazer T, Shah PS, Librach CL. Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:439–48.CrossRefPubMed Dar S, Lazer T, Shah PS, Librach CL. Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:439–48.CrossRefPubMed
15.
Zurück zum Zitat Racowsky C, Combelles CMH, Nureddin A, Pan Y, Finn A, Miles L, et al. Day 3 and day 5 morphological predictors of embryo viability. Reprod Biomed Online. 2003;6:323–31.CrossRefPubMed Racowsky C, Combelles CMH, Nureddin A, Pan Y, Finn A, Miles L, et al. Day 3 and day 5 morphological predictors of embryo viability. Reprod Biomed Online. 2003;6:323–31.CrossRefPubMed
16.
Zurück zum Zitat Ceyhan ST, Jackson K V., Racowsky C. Biennial Review of Infertility Voorhis BJ, Schlegel PN, Racowsky C, Carrell DT, editors. S. Temel Ceyhan, Katharine V. Jackson, Catherine Racowsky. Sel. Most Competent Embryo. Totowa, NJ: Humana Press; 2009. Ceyhan ST, Jackson K V., Racowsky C. Biennial Review of Infertility Voorhis BJ, Schlegel PN, Racowsky C, Carrell DT, editors. S. Temel Ceyhan, Katharine V. Jackson, Catherine Racowsky. Sel. Most Competent Embryo. Totowa, NJ: Humana Press; 2009.
17.
Zurück zum Zitat Gardner DK, Schoolcraft WB. In vitro culture of human blastocysts. Towar. Reprod. Certain. Fertil. Genet. Beyond 1999 Plenary Proc. 11th World Congr. 1999. p. 378–88. Gardner DK, Schoolcraft WB. In vitro culture of human blastocysts. Towar. Reprod. Certain. Fertil. Genet. Beyond 1999 Plenary Proc. 11th World Congr. 1999. p. 378–88.
18.
Zurück zum Zitat Rubio C, Rodrigo L, Mercader A, Mateu E, Buendía P, Pehlivan T, et al. Impact of chromosomal abnormalities on preimplantation embryo development. Prenat Diagn. 2007;27:748–56.CrossRefPubMed Rubio C, Rodrigo L, Mercader A, Mateu E, Buendía P, Pehlivan T, et al. Impact of chromosomal abnormalities on preimplantation embryo development. Prenat Diagn. 2007;27:748–56.CrossRefPubMed
19.
Zurück zum Zitat Zakharova EE, Zaletova VV, Krivokharchenko AS. Biopsy of human morula-stage embryos: outcome of 215 IVF/ICSI cycles with PGS. PLoS One. 2014;9:e106433.CrossRefPubMedPubMedCentral Zakharova EE, Zaletova VV, Krivokharchenko AS. Biopsy of human morula-stage embryos: outcome of 215 IVF/ICSI cycles with PGS. PLoS One. 2014;9:e106433.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Fanchin R, Ayoubi JM, Righini C, Olivennes F, Schönauer LM, Frydman R. Uterine contractility decreases at the time of blastocyst transfers. Hum Reprod. 2001;16:1115–9.CrossRefPubMed Fanchin R, Ayoubi JM, Righini C, Olivennes F, Schönauer LM, Frydman R. Uterine contractility decreases at the time of blastocyst transfers. Hum Reprod. 2001;16:1115–9.CrossRefPubMed
21.
Zurück zum Zitat Gardner DK, Balaban B. Choosing between day 3 and day 5 embryo transfers. Clin Obstet Gynecol. 2006;49:85–92.CrossRefPubMed Gardner DK, Balaban B. Choosing between day 3 and day 5 embryo transfers. Clin Obstet Gynecol. 2006;49:85–92.CrossRefPubMed
22.
Zurück zum Zitat Biggers JD, Racowsky C. The development of fertilized human ova to the blastocyst stage in KSOM(AA) medium: is a two-step protocol necessary? Reprod. Biomed. Online;5:133–40. Biggers JD, Racowsky C. The development of fertilized human ova to the blastocyst stage in KSOM(AA) medium: is a two-step protocol necessary? Reprod. Biomed. Online;5:133–40.
23.
Zurück zum Zitat Machtinger R, Racowsky C. Culture systems: single step. Methods Mol Biol. 2012;912:199–209.PubMed Machtinger R, Racowsky C. Culture systems: single step. Methods Mol Biol. 2012;912:199–209.PubMed
24.
Zurück zum Zitat Quinn P. Culture systems: sequential. Methods Mol Biol. 2012;912:211–30.PubMed Quinn P. Culture systems: sequential. Methods Mol Biol. 2012;912:211–30.PubMed
Metadaten
Titel
Building a model to increase live birth rate through patient-specific optimization of embryo transfer day
verfasst von
R. H. Goldman
D. J. Kaser
S. A. Missmer
S. S. Srouji
L. V. Farland
C. Racowsky
Publikationsdatum
10.09.2016
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 11/2016
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-016-0803-4

Weitere Artikel der Ausgabe 11/2016

Journal of Assisted Reproduction and Genetics 11/2016 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.